Harmony Biosciences Holdings (HRMY) Current Assets (2019 - 2026)

Harmony Biosciences Holdings (HRMY) has 8 years of Current Assets data on file, last reported at $778.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 21.18% year-over-year to $778.8 million; the trailing twelve-month figure through Mar 2026 stood at $778.8 million (up 21.18% YoY), and the FY2025 full-year result was $907.0 million, up 56.58% from the prior year.
• Current Assets fell to $778.8 million in Q1 2026, from $907.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $907.0 million in Q4 2025 to a low of $280.3 million in Q1 2022.
• A 5-year average of $533.6 million and a median of $463.0 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets rose 0.59% in 2024 and jumped 60.57% in 2025, its largest moves.
• Tracing HRMY's Current Assets over 5 years: stood at $400.3 million in 2022, then increased by 12.69% to $451.1 million in 2023, then rose by 28.42% to $579.3 million in 2024, then jumped by 56.58% to $907.0 million in 2025, then decreased by 14.13% to $778.8 million in 2026.
• Business Quant data shows HRMY's Current Assets at $778.8 million in Q1 2026, $907.0 million in Q4 2025, and $838.8 million in Q3 2025.